| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |